CorMedix, Inc. (AMEX:CRMD) announced its results for the quarter ended September 30, 2010. Appointment of Two Key Positions: Dr. Robert D. Hopkins as Head of Clinical Operations and Project Management and Mr. Dilip Wadgaonkar Head of Product Development and Manufacturing. Continued to Advance Patient Enrollment in Phase II Deferiprone CRMD001 for Prevention of Contrast Induced Nephropathy – 3rd Most Common Cause of Hospital Acquired Renal Insufficiency. Entered Final Stages of Manufacturing Scale-up of Neutrolin for the Prevention of Catheter Related Bloodstream Infection (CRBI) and Maintenance of Catheter Function in Hemodialysis Patients – A Significant Unmet Medical Need for Dialysis Patients.
CorMedix, Inc., a development-stage biopharmaceutical company, develops, manufactures, and markets products that lock a patient's central venous catheter between hemodialysis sessions to keep it free of infection and clots. It provides CMX001 that reduces oxidative stress due to excess labile iron; CMX002, a diagnostic test for chronic kidney disease; CMX003, an antimicrobial/anticoagulant solution; and CMX004, a pressure-sensitive gel. The company was incorporated in 2006 and is based in Bridgewater, New Jersey.
Midway Gold Corp. (AMEX:MDW) announced on November 22, 2010 that it has closed its previously announced unit offering. Pursuant to the offering, Midway raised aggregate gross proceeds of US$4 million, through the issue of 6,660,000 units through a brokered offering in Canada and the United States. The units were issued at US$0.60 per unit, each unit comprising one common share and one half of one non-transferable common share purchase warrant. Each whole warrant will entitle the holder to purchase one common share of Midway at a price of US$0.90 per share until November 22, 2012. Midway can accelerate the expiry of the warrants to a date 30 days after giving notice to the holders of such warrants if the common shares of Midway trade at a volume weighted average price of greater than US$1.15 per share for a period of 20 consecutive trading days on the NYSE-Amex.
Midway Gold Corp. engages in the acquisition, exploration, and development of gold and silver mineral properties in North America. It primarily explores the Midway, Spring Valley, and Pan gold and silver mineral properties located in Nevada; and the Golden Eagle gold mineral property located in Washington. The company was formerly known as Red Emerald Resource Corp. and changed its name to Midway Gold Corp. in July 2002. Midway Gold Corp. was founded in 1996 and is based in White Rock, Canada.
Power3 Medical Products, Inc. (OTC:PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
“In preparation for commercialization, our objective at this meeting was to show how Power3’s protein biomarkers and blood tests provide superior solutions for diagnosis and drug response to improve the treatment of Alzheimer’s disease,” stated Dr. Ira L. Goldknopf, PWRM ’s President & Chief Scientific Officer. “It was gratifying to receive substantial attention to our posters from representatives of major pharma and clinical research institutions from around the world. They expressed surprise and enthusiasm for our findings, especially those relating to the methods by which Power3’s protein biomarkers indicate how patients respond to treatment with the three major anti-dementia drugs.”
“We are pleased that our blood tests specifically diagnose Alzheimer’s in patients, both pre- and post-treatment,” commented Helen R. Park, MS, CEO of PWRM, “and that our scientific collaborators, Dr. Marwan Sabbagh, Medical and Scientific Director of the Banner Sun Health Medical Research Institute, and Dr. Lourdes R. Bosquez, President of the Woodlands Behavioral Institute, Inc., presented along with us at the meeting in Hawaii.”
“We are within striking distance of realizing an Alzheimer’s clinical diagnostic tool which I hope will lead to a greater understanding of the disease and buoy the pace of future therapeutic interventions,” added Marwan Sabbagh MD, Medical and Scientific Director of Banner Sun Health Medical Research Institute.
To learn more about PWRM visit: http://www.Power3Medical.com
MusclePharm Corporation (OTCQB:MSLP)
MusclePharm(NYSE:R) Corporation (OTCBB:MSLP) recently announced the Company signed Obi Obadike, World Body & Fitness Federation Pro-Male Fitness Model World Champion and 2010 FMI Male Fitness Model Of The Year, to join Team MusclePharm.
"I joined MusclePharm because I truly believe they have the best supplement products on the market that will help assist people of all ages attain their fitness goals. In addition to great products being associated with a brand like MusclePharm and top athlete superstars like NFL Pro Joey Porter, NFL Pro Shawn Merriman, MMA Superstars Rashad Evans and Anderson Silvia is an honor and privilege. I believe it is clearly evident that MusclePharm is going to dominate and take over the fitness industry globally and I want to be a part of that success."
Obi Obadike is the only fitness personality/fitness model in the world that is a fitness expert columnist for ten different fitness magazines globally with a following of over 2 million readers. He was recently voted "The World's Most Ripped Fitness Model" and was recently selected one of the top 20 most influential fitness people on the web. Obadike was a former Division I sprinter at Cal State Fullerton where he held the University record in the 100 and 200 meters, as well as the 400 meter relay. In addition, he held the title of the fastest man in Cal State Fullerton history for a five year period. He is one of the most educated fitness professionals in the fitness industry with two bachelor's and a masters degree. President of MusclePharm, Cory Gregory states, "We believe that Obi Obadike is the number one fitness model in the world right now. His marketability, education and global notoriety within the fitness industry will be an invaluable asset to the MusclePharm team."
We are Strong...We are Driven...We are MusclePharm
To learn more about MSLP visit: http://www.musclepharm.com
Vringo, Inc. (AMEX:VRNG) announced on November 29, 2010 that it has signed an agreement with Turner Broadcasting in the UK. Under the terms of the agreement, Turner Broadcasting will license Adult Swim content to Vringo, which will create video ringtones using content from a range of popular Adult Swim television shows including Robot Chicken, Aqua Teen Hunger Force and Metalocalypse. Vringo will make the new Adult Swim video ringtone content available for purchase on the Android Marketplace, Nokia's Ovi Store and the stores of mobile operators such as Orange UK where Vringo will be launching its service later this quarter.
Vringo, Inc. provides a platform that allows users to create, download, and share mobile entertainment content in the form of video ringtones for mobile phones. By installing its application, users can create or take video, images, and slideshows from virtually anywhere, including Vringo's library of 5,000-and-counting video ringtone clips or the Web, and make it into their personal call signature. The company was founded in 2006 and is based in New York, New York.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE) has received five thousand dollars and anticipates receiving another forty five thousand dollars in cash from a third party for 30 (thirty) days of advertising for MusclePharm Corporation (OTCQB:MSLP). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).